Is the use of modafinil, a pharmacological cognitive enhancer, cheating?

References

• Abdullah, Abdul, Doucouliagos, Hristos, and Manning, Elizabeth. 2015. “Does Education Decrease Income Inqeuality? A Meta-Regression Analysis.” Journal of Economic Surveys 29: 301–316. doi:10.1111/joes.12056.
   Google Scholar
• Aikins, Ross, Xiaoxue Zhang, and Sean Esteban McCabe. 2017. “Academic Doping: Institutional Policies regarding Nonmedical Use of Prescription Stimulants in U.S. Higher Education.” Journal of Academic Ethics 15: 229–243.10.1007/s10805-017-9291-0
   Web of Science ®Google Scholar
• Andrade, Chittaranjan, Steve Kisely, Ingrid Monteiro, and Sanjay Rao. 2015. “Antipsychotic Augmentation with Modafinil or Armodafinil for Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials.” Journal of Psychiatric Research 60: 14–21. doi:10.1016/j.jpsychires.2014.09.013.
   PubMed Web of Science ®Google Scholar
• Battleday, R. M., and A.-K. Brem. 2015. “Modafinil for Cognitive Neuroenhancement in Healthy Non-sleep-deprived Subjects: A Systematic Review.” European Neuropsychopharmacology, August.. doi:10.1016/j.euroneuro.2015.07.028.
   Web of Science ®Google Scholar
• Baum, Lyman Frank. 1910. “The Emerald City of Oz.” http://www.worldwideschool.org/library/books/youth/landofoz/TheEmeraldCityofOz/chap9.html.
   Google Scholar
• Beddington, John, Cary L. Cooper, John Field, Usha Goswami, Felicia A. Huppert, Rachel Jenkins, Hannah S. Jones, Tom B. L. Kirkwood, Barbara J. Sahakian, and Sandy M. Thomas. 2008. “The Mental Wealth of Nations.” Nature 455 (7216). Nature Publishing Group: 1057–1060. doi:10.1038/4551057a.
   PubMed Web of Science ®Google Scholar
• Behrman, Jere R., and Nevzer Stacey. 1997. The Social Benefits of Education. Ann Arbor: University of Michigan Press.10.3998/mpub.15129
   Google Scholar
• Cabrera, Laura Y., Nicholas S. Fitz, and Peter B. Reiner. 2014. “Reasons for Comfort and Discomfort with Pharmacological Enhancement of Cognitive, Affective, and Social Domains.” Neuroethics 8 (2): 93–106. doi:10.1007/s12152-014-9222-3.
   Web of Science ®Google Scholar
• del Campo, Natalia, Tim D. Fryer, Young T. Hong, Rob Smith, Laurent Brichard, Julio Acosta-Cabronero, Samuel R. Chamberlain, et al. 2013. “A Positron Emission Tomography Study of Nigro-Striatal Dopaminergic Mechanisms Underlying Attention: Implications for ADHD and Its Treatment.” Brain : A Journal of Neurology 136 (Pt 11): 3252–3270. doi:10.1093/brain/awt263.
   PubMed Web of Science ®Google Scholar
• Carstairs, Shaun D., Andrew Urquhart, Justin Hoffman, Richard F. Clark, and F. Lee Cantrell. 2010. “A Retrospective Review of Supratherapeutic Modafinil Exposures.” Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology 6 (3): 307–310. doi:10.1007/s13181-010-0017-6.
   PubMedGoogle Scholar
• Chapman, Julia L., Andrew Vakulin, Jan Hedner, Brendon J. Yee, and Nathaniel S. Marshall. 2016. “Modafinil/Armodafinil in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.” European Respiratory Journal 47 (5): 1420–1428. doi:10.1183/13993003.01509-2015.
   PubMed Web of Science ®Google Scholar
• Covassin, Naima, and Prachi Singh. 2016. “Sleep Duration and Cardiovascular Disease Risk.” Sleep Medicine Clinics 11 (1): 81–89. doi:10.1016/j.jsmc.2015.10.007.
   PubMed Web of Science ®Google Scholar
• Cryer, Byron. 2005. “NSAID-Associated Deaths: The Rise and Fall of NSAID-Associated GI Mortality.” The American Journal of Gastroenterology 100 (8): 1694–1695. doi:10.1111/j.1572-0241.2005.50565.x.
   PubMed Web of Science ®Google Scholar
• Dubljević, Veljko. 2013. “Prohibition or Coffee Shops: Regulation of Amphetamine and Methylphenidate for Enhancement Use by Healthy Adults.” The American Journal of Bioethics: AJOB 13 (7): 23–33. doi:10.1080/15265161.2013.794875.
   PubMed Web of Science ®Google Scholar
• Ellenbogen, J. M. 2005. “Cognitive Benefits of Sleep and Their Loss due to Sleep Deprivation.” Neurology 64 (7): E25–E27. doi:10.1212/01.wnl.0000164850.68115.81.
   PubMed Web of Science ®Google Scholar
• Ferrie, Jane E., Martin J. Shipley, Tasnime N. Akbaraly, Michael G. Marmot, Mika Kivimäki, and Archana Singh-Manoux. 2011. “Change in Sleep Duration and Cognitive Function: Findings from the Whitehall II Study.” Sleep 34 (5). American Academy of Sleep Medicine: 565–573. /pmc/articles/PMC3079935/?report=abstract.10.1093/sleep/34.5.565
   PubMed Web of Science ®Google Scholar
• Ficca, Gianluca, John Axelsson, Daniel J. Mollicone, Vincenzo Muto, and Michael V. Vitiello. 2010. “Naps, Cognition and Performance.” Sleep Medicine Reviews 14 (4): 249–258. doi:10.1016/j.smrv.2009.09.005.
   PubMed Web of Science ®Google Scholar
• Finke, Kathrin, Chris M. Dodds, Peter Bublak, Ralf Regenthal, Frank Baumann, Tom Manly, and Ulrich Müller. 2010. “Effects of Modafinil and Methylphenidate on Visual Attention Capacity: A TVA-Based Study.” Psychopharmacology 210 (3): 317–329. doi:10.1007/s00213-010-1823-x.
   PubMed Web of Science ®Google Scholar
• Forlini, Cynthia, and Eric Racine. 2009. “Autonomy and Coercion in Academic ‘Cognitive Enhancement’ Using Methylphenidate: Perspectives of Key Stakeholders.” Neuroethics 2 (3): 163–177. doi:10.1007/s12152-009-9043-y.
   Web of Science ®Google Scholar
• Fox, Kieran C. R., Savannah Nijeboer, Matthew L. Dixon, James L. Floman, Melissa Ellamil, Samuel P. Rumak, Peter Sedlmeier, and Kalina Christoff. 2014. “Is Meditation Associated with Altered Brain Structure? A Systematic Review and Meta-analysis of Morphometric Neuroimaging in Meditation Practitioners.” Neuroscience and Biobehavioral Reviews 43 (June): 48–73. doi:10.1016/j.neubiorev.2014.03.016.
   PubMedGoogle Scholar
• Franke, Andreas G., Caroline Bonertz, Michaela Christmann, Stefan Engeser, and Klaus Lieb. 2012. “Attitudes toward Cognitive Enhancement in Users and Nonusers of Stimulants for Cognitive Enhancement: A Pilot Study.” AJOB Primary Research 3 (1). Taylor & Francis Group: 48–57. doi:10.1080/21507716.2011.608411.
   Google Scholar
• Gallicchio, Lisa, and Bindu Kalesan. 2009. “Sleep Duration and Mortality: A Systematic Review and Meta-Analysis.” Journal of Sleep Research 18 (2): 148–158. doi:10.1111/j.1365-2869.2008.00732.x.
   PubMed Web of Science ®Google Scholar
• Harris, John. 1985. The Value of Life. Oxford: Routledge Publishing Group.
   Google Scholar
• Jasinski, D. R. 2000. “An Evaluation of the Abuse Potential of Modafinil Using Methylphenidate as a Reference.” Journal of Psychopharmacology (Oxford, England) 14 (1): 53–60. http://www.ncbi.nlm.nih.gov/pubmed/10757254.10.1177/026988110001400107
   PubMed Web of Science ®Google Scholar
• Khoury, Bassam, Manoj Sharma, Sarah E. Rush, and Claude Fournier. 2015. “Mindfulness-based Stress Reduction for Healthy Individuals: A Meta-Analysis.” Journal of Psychosomatic Research 78 (6): 519–528. doi:10.1016/j.jpsychores.2015.03.009.
   PubMed Web of Science ®Google Scholar
• Khoury, Bassam, Bärbel Knäuper, Marco Schlosser, Kimberly Carrière, and Alberto Chiesa. 2017. “Effectiveness of Traditional Meditation Retreats: A Systematic Review and Meta-Analysis.” Journal of Psychosomatic Research 92 (January): 16–25. doi:10.1016/j.jpsychores.2016.11.006.
   PubMedGoogle Scholar
• Kollins, S. H., E. K. MacDonald, and C. R. Rush. 2001. “Assessing the Abuse Potential of Methylphenidate in Nonhuman and Human Subjects: A Review.” Pharmacology, Biochemistry, and Behavior 68 (3): 611–627 http://www.ncbi.nlm.nih.gov/pubmed/11325419.10.1016/S0091-3057(01)00464-6
   PubMed Web of Science ®Google Scholar
• Kumar, Raminder. 2008. “Approved and Investigational Uses of Modafinil : An Evidence-Based Review.” Drugs 68 (13): 1803–1839 http://www.ncbi.nlm.nih.gov/pubmed/18729534.10.2165/00003495-200868130-00003
   PubMed Web of Science ®Google Scholar
• Lanas, Angel, Maria Angeles Perez-Aisa, Faust Feu, Julio Ponce, Esteban Saperas, Santos Santolaria, Luis Rodrigo, et al. 2005. “A Nationwide Study of Mortality Associated with Hospital Admission due to Severe Gastrointestinal Events and Those Associated with Nonsteroidal Antiinflammatory Drug Use.” The American Journal of Gastroenterology 100 (8). The American College of Gastroenterology: 1685–1693. doi:10.1111/j.1572-0241.2005.41833.x.
   PubMed Web of Science ®Google Scholar
• Lewis, Harry R. 2006. Excellence without a Soul: How a Great University Forgot Education. New York: PublicAffairs.
   Google Scholar
• Lochner, L. 2011. “Non-Production Benefits of Education: Crime, Health, and Good Citizenship.” In Handbook of the Economics of Education, edited by E. Hanushek, S. Machin and L. Woessmann, 183–282. Amsterdam: Elsevier Science.
   Google Scholar
• Lovato, Nicole, and Leon Lack. 2010. “The Effects of Napping on Cognitive Functioning.” Progress in Brain Research 185: 155–166. doi:10.1016/B978-0-444-53702-7.00009-9.
   PubMed Web of Science ®Google Scholar
• Maher, Brendan. 2008. “Poll Results: Look Who's Doping.” Nature 452 (7188): 674–675. doi:10.1038/452674a.
   PubMed Web of Science ®Google Scholar
• Maier, Larissa J., Matthias E. Liechti, Fiona Herzig, and Michael P. Schaub. 2013. “To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students.” PLoS One 8 (11): e77967. doi:10.1371/journal.pone.0077967.
   PubMed Web of Science ®Google Scholar
• Mehta, M., B. J. Sahakian, and T. W. Robbins. 2001. “Comparative Psychopharmacology of Methylphenidate and Related Drugs in Human Volunteers, Patients with ADHD and Experimental Animals.” In Stimulant Drugs and ADHD: Basic and Clinical Findings, edited by M. V. Solanto, A. F. T. Arnsten and F. X. Castellanos, 303–331. New York: Oxford University Press.
   Google Scholar
• Müller, U., J. B. Rowe, T. Rittman, C. Lewis, T. W. Robbins, and B. J. Sahakian. 2013. “Effects of Modafinil on Non-verbal Cognition, Task Enjoyment and Creative Thinking in Healthy Volunteers.” Neuropharmacology 64 (January): 490–495. doi:10.1016/j.neuropharm.2012.07.009.
   PubMedGoogle Scholar
• Northstone, Kate, Carol Joinson, Pauline Emmett, Andy Ness, and Tomás Paus. 2012. “Are Dietary Patterns in Childhood Associated with IQ at 8 Years of Age? A Population-Based Cohort Study.” Journal of Epidemiology and Community Health 66 (7): 624–628. doi:10.1136/jech.2010.111955.
   PubMed Web of Science ®Google Scholar
• Olthof, Bas, Anco Peeters, Kimberly Schelle, and Pim Haselager. 2013. “If You’re Smart, We’ll Make You Smarter. Applying the Reasoning behind the Development of Honours Programmes to Other Forms of Cognitive Enhancement.” http://philpapers.org/rec/OLTIYS.
   Google Scholar
• Porsdam Mann, Sebastian, and Barbara J. Sahakian. 2015. “The Increasing Lifestyle Use of Modafinil by Healthy People: Safety and Ethical Issues.” Current Opinion in Behavioral Sciences 4 (August): 136–141. doi:10.1016/j.cobeha.2015.05.004.
   Google Scholar
• President’s Council on Bioethics. 2003. “Beyond Therapy: Biotechnology and the Pursuit of Happiness.” http://www.amazon.co.uk/Beyond-Therapy-Biotechnology-Happiness-Presidents/dp/0060734906.
   Google Scholar
• Randall, Delia C., John M. Shneerson, and Sandra E. File. 2005. “Cognitive Effects of Modafinil in Student Volunteers May Depend on IQ.” Pharmacology Biochemistry and Behavior 82 (1): 133–139. doi:10.1016/j.pbb.2005.07.019.
   PubMed Web of Science ®Google Scholar
• Roth, Michael S. 2014. Beyond the University: Why Liberal Education Matters. New Haven, CT: Yale University Press.
   Google Scholar
• Rugino, Thomas. 2007. “A Review of Modafinil Film-Coated Tablets for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.” Neuropsychiatric Disease and Treatment 3 (3): 293–301 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2654790&tool=pmcentrez&rendertype=abstract.
   PubMedGoogle Scholar
• Sabatine, Marc S., Kian-Keong Poh, Jessica L. Mega, Jo-Anne O. Shepard, James R. Stone, and Matthew P. Frosch. 2007. “Case Records of the Massachusetts General Hospital. Case 36-2007. A 31-Year-Old Woman with Rash, Fever, and Hypotension.” The New England Journal of Medicine 357 (21): 2167–2178. doi:10.1056/NEJMcpc079030.
   PubMedGoogle Scholar
• Sahakian, Barbara, and Sharon Morein-Zamir. 2007. “Professor’s Little Helper.” . Nature 450 (7173). Nature Publishing Group: 1157–1159. doi:10.1038/4501157a.
   PubMed Web of Science ®Google Scholar
• Sandel, Michael J. 2007. The Case against Perfection. Harvard University Press. https://books.google.com/books?hl=en&lr=&id=ael6tIvalIUC&pgis=1.
   Google Scholar
• Sattler, Sebastian, Guido Mehlkop, Peter Graeff, and Carsten Sauer. 2014. “Evaluating the Drivers of and Obstacles to the Willingness to Use Cognitive Enhancement Drugs: The Influence of Drug Characteristics, Social Environment, and Personal Characteristics.” Substance Abuse Treatment, Prevention, and Policy 9 (January): 8. doi:10.1186/1747-597X-9-8.
   PubMedGoogle Scholar
• Schelle, Kimberly J., Nadira Faulmüller, Lucius Caviola, and Miles Hewstone. 2014. “Attitudes toward Pharmacological Cognitive Enhancement – A Review.” Frontiers in Systems Neuroscience 8 (January): 53. doi:10.3389/fnsys.2014.00053.
   PubMedGoogle Scholar
• Schelle, Kimberly J., Bas M. J. Olthof, Wesley Reintjes, Carsten Bundt, Joyce Gusman-Vermeer, and Anke C. C. M. van Mil. 2015. “A Survey of Substance Use for Cognitive Enhancement by University Students in the Netherlands.” Frontiers in Systems Neuroscience 9 (January): 10. doi:10.3389/fnsys.2015.00010.
   PubMedGoogle Scholar
• Schermer, M. 2008. “On the Argument That Enhancement is ‘Cheating’.” Journal of Medical Ethics 34 (2): 85–88. doi:10.1136/jme.2006.019646.
   PubMed Web of Science ®Google Scholar
• Singh, G. 1998. “Recent Considerations in Nonsteroidal Anti-Inflammatory Drug Gastropathy.” The American Journal of Medicine 105 (1B): 31S–38S http://www.ncbi.nlm.nih.gov/pubmed/9715832.10.1016/S0002-9343(98)00072-2
   PubMedGoogle Scholar
• Smith, M. Elizabeth, and Martha J. Farah. 2011. “Are Prescription Stimulants ‘Smart Pills’? The Epidemiology and Cognitive Neuroscience of Prescription Stimulant Use by Normal Healthy Individuals.” Psychological Bulletin 137 (5): 717–741. doi:10.1037/a0023825.
   PubMed Web of Science ®Google Scholar
• Stiglitz, Joseph E. 1999. “Knowledge as a Global Public Good.” In Global Public Goods: International Cooperation in the 21st Century, edited by Inge Kaul, Isabelle Grunberg and Marc Stern, 308–325. Oxford: Oxford University Press. http://s1.downloadmienphi.net/file/downloadfile6/151/1384343.pdf#page=346.10.1093/0195130529.001.0001
   Google Scholar
• Thornton, Jane S., Pierre Frémont, Karim Khan, Paul Poirier, Jonathon Fowles, Greg D. Wells, and Renata J. Frankovich. 2016. “Physical Activity Prescription: A Critical Opportunity to Address a Modifiable Risk Factor for the Prevention and Management of Chronic Disease: A Position Statement by the Canadian Academy of Sport and Exercise Medicine: Table 1.” British Journal of Sports Medicine 50 (18): 1109–1114. doi:10.1136/bjsports-2016-096291.
   PubMed Web of Science ®Google Scholar
• Titz, Cora, and Julia Karbach. 2014. “Working Memory and Executive Functions: Effects of Training on Academic Achievement.” Psychological Research 78 (6): 852–868. doi:10.1007/s00426-013-0537-1.
   PubMed Web of Science ®Google Scholar
• Umberson, Debra, and Jennifer Karas Montez. 2010. “Social Relationships and Health: A Flashpoint for Health Policy.” Journal of Health and Social Behavior 51 (Suppl). NIH Public Access: S54–S66. doi:10.1177/0022146510383501.
   PubMed Web of Science ®Google Scholar
• Volkow, Nora D., Joanna S. Fowler, Jean Logan, David Alexoff, Wei Zhu, Frank Telang, Gene-Jack Wang, et al. 2009. “Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain.” JAMA 301 (11): 1148. doi:10.1001/jama.2009.351.
   PubMed Web of Science ®Google Scholar
• Vrecko, Scott. 2013. “Just How Cognitive is ‘Cognitive Enhancement’? On the Significance of Emotions in University Students’ Experiences with Study Drugs.” AJOB Neuroscience 4 (1): 4–12. doi:10.1080/21507740.2012.740141.
   PubMedGoogle Scholar
• Wang, Sheng-Min, Changsu Han, Soo-Jung Lee, Tae-Youn Jun, Ashwin A. Patkar, Prakash S. Masand, and Chi-Un Pae. 2017. “Modafinil for the Treatment of Attention-deficit/Hyperactivity Disorder: A Meta-analysis.” Journal of Psychiatric Research 84: 292–300. doi:10.1016/j.jpsychires.2016.09.034.
   PubMed Web of Science ®Google Scholar
• Winterstein, Almut G., Tobias Gerhard, Jonathan Shuster, Michael Johnson, Julie M. Zito, and Arwa Saidi. 2007. “Cardiac Safety of Central Nervous System Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.” Pediatrics 120 (6): e1494–e1501. doi:10.1542/peds.2007-0675.
   PubMed Web of Science ®Google Scholar